European Commission logo
français français
CORDIS - Résultats de la recherche de l’UE
CORDIS

Excel in Rare Diseases’ Research: Focus on LYSOsomal Disorders and CILiopathies

Description du projet

Unir les chercheurs contre les maladies rares

Les maladies rares représentent un défi important pour la médecine et la recherche en raison du nombre limité de patients et donc d’échantillons disponibles. Pour améliorer la qualité de vie des patients et de leurs familles, il est urgent de mettre en place des collaborations internationales permettant de partager les connaissances, les ressources et les innovations. L’objectif principal du projet LYSOCIL, financé par l’UE, consiste à mettre en place un réseau intégré de collaborations pour renforcer la recherche contre les maladies chroniques rares au Portugal et dans le reste de l’Europe. Le réseau se concentre sur la compréhension des mécanismes à l’origine des maladies lysosomales et des ciliopathies, le but ultime étant de concevoir de nouvelles thérapies.

Objectif

The high diversity, low numbers and scattered distribution of patients affected rare diseases (RDs) represent a big challenge for biomedical research and health care, the patients and their families.
International cooperation is paramount to understand the etiology and find better diagnostic procedures for RDs. LYSOCIL addresses that need through a scientific strategy to reinforce research and innovation excellence in the study of lysosomal diseases and ciliopathies, with a special attention on the diagnosis and etiology of these diseases.
The Chronic Diseases Research Center of the NOVA Medical School (UNL-NMS-CEDOC) aims to be at the forefront of European and international scientific excellence in chronic RDs. Towards this goal, UNL-NMS-CEDOC is twinning with two internationally leading research institutions, the Münster University (WWU) and the Telethon Institute of Genetics and Medicine (TIGEM - FTELE.IGM). LYSOCIL will leverage on WWU and TIGEM’s outstanding multidisciplinary knowledge and experience, research and training best practices, as well as collaborative networks to enhance the research capacity and innovation potential of CEDOC-NMS.
LYSOCIL is an integrated network of interactions (exchange and training of researchers, satellite meetings, Winter Retreats, virtual think tanks, etc.), articulated with the individual and joint scientific agendas of the partners, to power the research capacity of CEDOC-NMS and of its local and national ecosystems. LYSOCIL expects to increase by 20% in multiple indicators by 2021, including the number of citations; h-index of UNL-NMS-CEDOC researchers; percentage of publications in top impact journals; number of international collaborations and publications.
By stimulating novel and long-lasting interactions between UNL-NMS-CEDOC, WWU and TIGEM (FTELE.GM) l unlock the research potential within and outside CEDOC-NMS, with an overall increase in the Portuguese and European RD research competitiveness.

Appel à propositions

H2020-WIDESPREAD-2016-2017

Voir d’autres projets de cet appel

Sous appel

H2020-WIDESPREAD-05-2017-Twinning

Coordinateur

UNIVERSIDADE NOVA DE LISBOA
Contribution nette de l'UE
€ 626 878,75
Adresse
CAMPUS DE CAMPOLIDE
1099 085 Lisboa
Portugal

Voir sur la carte

Région
Continente Área Metropolitana de Lisboa Área Metropolitana de Lisboa
Type d’activité
Higher or Secondary Education Establishments
Liens
Coût total
€ 626 878,75

Participants (2)